A large body of evidence has formed implicating long-term exposures to particulate matter (PM) air pollution with an increased risk of cardiovascular disease (CVD) morbidity and mortality, 1, 2 leading to the recognition of air pollution as a major risk factor for these outcomes. 3, 4 For example, as part of the Global Burden of Disease 2010 project, ambient PM exposure was estimated to be responsible for 1.5 million ischemic heart disease deaths in 2010 with population-attributable fractions of 2% to 41%, depending on the country. 5 In a recent review of the evidence from longterm studies, each 10 lg/m 3 increase in PM <2.5 microns in aerodynamic diameter (PM 2.5 ) was associated with an 11% (95% CI: 5 to 16) increased risk of cardiovascular mortality. 2 Although the majority of studies have observed elevated risks with PM exposures, statistically significant heterogeneity in these estimates has been observed, even within studies. [6] [7] [8] [9] Differences in the prevalence of risk factors and different proportions of susceptible subpopulations may underlie this heterogeneity. Therefore, the subpopulations at the greatest risk remain a key question in the literature. Among women in the Nurses' Health Study (NHS) living in the Northeastern and Midwestern regions of the United States 1992-2002, we have previously observed an increased risk of incident overall coronary heart disease (CHD), fatal CHD, and nonfatal myocardial infarctions (MI) with increasing long-term exposures to PM 2.5 , and evidence of heterogeneity by personal characteristics. 10 Our current objectives are to spatially (to the full contiguous United States) and temporally (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) expand our examination of these associations, to determine whether there is heterogeneity in effect esti-mates by region of the country or by personal characteristics including cardiovascular risk factors, to compare heterogeneity in effects across PM size fractions, and to assess the impact of these exposures on the risk of incident stroke, in addition to incident CHD.
Methods Study Population
The NHS is a prospective cohort study of nurses started in 1976. At enrollment, the 121 701 women were 30 to 55 years of age, married, and completed a mailed questionnaire with detailed information on demographics, lifestyle characteristics, and prevalence of a number of diseases. Women were initially enrolled from a selection of 11 states; however, participants now live throughout the contiguous United States. Follow-up questionnaires are mailed every 2 years to update risk factor and disease status, and response rates have been consistently over 90%. All residential address locations have been geocoded to obtain longitude and latitude. Women were included in the current analyses if they remained alive and free of CVD through 1988, were still responding to questionnaires, and had at least a single address within the contiguous United States during 1988-2006 where air pollution predictions were available. The study protocol was approved by the Brigham and Women's Hospital Institutional Review Board, and consent was implied through the return of the questionnaires.
Outcome Assessment
On the baseline and all subsequent follow-up questionnaires, participants were asked to report all occurrences of physician diagnosed CVD, specifically, incidence of CHD or stroke. Women (or for fatal cases, next-of-kin) were asked to provide consent to review all medical records pertaining to their diagnosis. Cases of fatal CHD (ICD-8 and ICD-9 codes 410 to 412, ICD-10 codes I21 to I22) were classified as definite if confirmed by hospital records or through an autopsy, or if CHD was the most plausible cause of death and there was prior evidence of CHD. Cases were classified as probable if medical records surrounding the death were not available, but CHD was the underlying cause on the death certificate, National Death Index search, or a family member provided supporting information. Nonfatal MI was classified as definite if the criteria of the World Health Organization were met, specifically, symptoms and either electrocardiographdetected changes or elevated cardiac-enzyme concentrations. Cases of nonfatal MIs were designated as probable if an interview or letter confirming hospitalization for the infarction was obtained and medical records were unavailable. Overall incident CHD was determined based on the first occurrence of 12 The models used monthly average PM 2.5 and/or PM 10 monitoring data from the US Environmental Protection Agency's Air Quality System, the IMPROVE network, and other sources and the addresses were updated every 2 years. 13, 14 
Statistical Analyses
Person-months of follow-up were calculated from June 1989 through the end of follow-up, incidence of the specific event of interest, death, or loss to follow-up, whichever occurred first. Separate time-varying Cox proportional hazards models were used to assess the association of incident CVD, CHD, or stroke with 12-month time-varying averages of each size fraction of PM. Hazard ratios (HRs) and 95% CIs were calculated for each 10 lg/m 3 increase, after assessing the linearity of each dose-response with cubic regression splines. 18 The dataset was converted to an Anderson-Gill counting process structure with a record for each month that included the appropriate person-time, calculated exposure averages, censoring information, and covariates for that month of follow-up. All models were stratified by age in months and month of study to control for age and temporal effects. To examine effect modification, we calculated stratum-specific effect estimates and examined the statistical significance of any observed effect modification using likelihood ratio tests. In sensitivity analyses, we performed all analyses from 2000 forward, to determine whether the effect estimates were different in the time period where monitoring data on PM 2.5 was directly available for use in our spatio-temporal prediction models. In the later time period we also conducted sensitivity analyses to examine the impact of longer exposure periods (24-, 60-, and 120-month moving averages). An a level of 0.05 was used to determine statistical significance for main effects, and an a level of 0.0083 (0.05/6 potential modifiers) was used for effect modifiers.
Results
Among 114 537 NHS participants eligible for analysis, 6767 women developed CVD during 1 835 486 person-years of follow-up, and 3878 and 3295 incident cases of CHD and stroke, respectively, were confirmed during this time. A total of 96 058 women were available for analyses starting in 2000 (the first year PM 2.5 was widely monitored), accounting for 2413 incident CVD cases, 1301 incident CHDs, and 1194 incident strokes during 557 741 years of follow-up. Characteristics of the population throughout both follow-up periods are presented in Table 1 . During the full follow-up period, participants were 63.5 (SD=8.5) years old on average, were mainly white, married, and postmenopausal, and were never or former smokers. Characteristics were similar after 2000, with an average participant age of 68.6 (SD=7.3). The HRs for each outcome for a 10 lg/m 3 increase in each size fraction of PM are presented in Table 2 for both follow-up periods. In basic models adjusted for age, time period, region, and season, small increases in the risk of incident CVD, CHD, and stroke were observed for all size fractions of PM exposure. These increases only reached statistical significance for the association of PM 10 with total CVD, and for PM 2.5-10 with all 3 outcomes in the full period of follow-up. In multivariable models, the results were generally attenuated, and none reached statistical significance. Individual and area-level socioeconomic status appeared to be the most important confounders, and both attenuated the effect estimates for all size fractions. HRs tended to be more elevated for PM 2.5 in analyses with follow-up starting after 2000, while for PM 2.5 to 10 HRs were higher in the full period of follow-up. The 12-, 24-, 60-, and 120-month averages were highly correlated (Table 3) within each size fraction. Within each averaging period, PM 2.5 and PM 2.5-10 were weakly correlated (r0.2), PM 2.5 and PM 10 were moderately correlated (r0.6), and PM 10 and PM 2.5-10 were strongly correlated (r0.8). For CVD, averaging periods >12 months were associated with attenuations in risk for each of the size fractions; the HRs for each 10 lg/m 3 increase in PM 2.5 were 1.13, 1.08, 1.04, and
1.02 for the 12-, 24-, 60-, and 120-month exposure windows (Figure) . This pattern of attenuations was similar for analyses of stroke, but was less dramatic for analyses of total CHD. No statistically significant differences in effects were observed across regions in the full period of follow-up (Table 4) ; however, there was a suggestion of effect modification by region after 2000 (Table 5) , with higher HRs observed in the Northeast and South. Multivariable models stratified by selected cardiovascular risk factors are presented in Table 6 for the full follow-up period. For all 3 outcomes, HRs were higher among women with diabetes as compared to those without diabetes, and the test for interaction was statistically significant for the majority of the end points. Among women with diabetes, during the full period of follow-up, the HR of incident total CVD for a 10 lg/ m 3 increase in PM (Table 7) .
Discussion
In this nationwide prospective study, exposures to PM were associated with small, but nonstatistically significant, elevations in incident CVD, CHD, and stroke in this cohort of US women. However, there were consistently statistically significant elevations in risk for almost all PM size fractions and outcomes among women with diabetes. There were also suggestions of effect modification by region of residence, smoking status, obesity, and age, but they were not consistent across outcomes, size fractions, and time periods. Overall, we observed larger HRs in models restricted to the later time periods, especially for PM 2.5 . This may be due to effect modification by age, as there was a suggestion of higher HRs among older participants in the full follow-up period. These findings may also be due to improvements in our prediction models after 2000. Reductions in measurement error in these models would be expected to lead to increases in the HRs. However, there was overlap in the 95% CIs for the 2 time periods, so it is also possible that our findings of higher risks in the later time period are due to chance.
Our multivariable adjusted results in the full cohort for the full period of follow-up are generally lower than the majority of studies in the literature, including a previous analysis in the NHS cohort. 10, 15, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] Adjusted for age, time period, region, season, race, smoking status and pack-years, BMI, menopausal status and hormone use, hypercholesterolemia, hypertension, diabetes, family history of MI, and individual-and area-level SES as appropriate. BMI indicates body mass index; CHD, coronary heart disease; CVD, cardiovascular disease; HRs, hazard ratios; MI, myocardial infarction; PM, particulate matter; SES, socioeconomic status. *P-for-interaction below our a level for statistical significance of 0.0083. Continued mortality, with similar effect sizes for ischemic heart disease and cerebrovascular mortality. 16 Previously in the NHS, we observed suggestions of effect modification of our PM 2.5 results by a number of cardiovascular risk factors, although none of the modifiers reached statistical significance (defined as P<0.05). In analyses of PM 2.5 , higher HRs for total CHD were observed among women with diabetes, those with a family history of MI, individuals with hypercholesterolemia or hypertension, former and never smokers, and the obese. 15 A few recent long-term studies have systematically assessed effect modification to identify susceptible subpopulations with mixed results. In both ESCAPE analyses, no effect modification was observed by smoking status, BMI, or hypertension; diabetes was not considered as an effect modifier. 7, 8 Recent results from the Agricultural Health Study showed elevated risks of CVD mortality for increasing PM 2.5 exposures only among male participants. 9 Effect modification by BMI was observed, with the highest risks among men with a BMI ≥26.5 kg/m 2 . In the ACS, no statistically significant effect modification was observed by baseline report of diabetes, hypertension or existing heart disease. 16 A recent review of effect modification in studies of the effects of short-term PM exposures found strong evidence of effect modification by age, with higher risks among older individuals, weak or limited evidence of effect modification by sex and socioeconomic status, and no effect modification by race. 17 Short-term studies have also examined effect modification by diabetes, and most have suggested that individuals with diabetes are a susceptible subpopulation. 3, 4, [29] [30] [31] [32] [33] [34] Therefore, although there is consistent evidence that individuals with diabetes are particularly vulnerable to the cardiovascular effects of acute exposures to air pollution, our study is one of the first to demonstrate high risks of CVD among individuals with diabetes with longterm exposures to PM. Differences in susceptibility, especially among individuals with diabetes, have also been reported in studies designed to elucidate the biological mechanisms, typically inflammation, underlying the adverse health effects of PM. The most comparable studies, in terms of the populations studied and the PM 2.5 exposure averaging times used, have focused on the effects of PM 2.5 on C-reactive protein (CRP). In the longitudinal Study of Women's Health Across the Nation, associations between PM 2.5 averaged over the previous 12 months and CRP were strongest among women with diabetes, with a 72.1% increase (95% CI: 2.9 to 187.8) in CRP for each 10 lg/m 3 increase in PM 2.5 in the full study population and a 301% increase (no confidence interval provided) in CRP among the oldest participants with diabetes (aged 50.5 to 55 years of age at the start of the study). 35 In the German Heinz Nixdorf Recall Study, increases in annual average PM 2.5 were associated with increases in CRP in only male participants. However, each 3.91 lg/m 3 increase in PM 2.5 was associated with an 82.6%
increase (95% CI: 1.1 to 230.3) in CRP among women with diabetes, which was the largest increase observed among a number of subgroups examined. 36 Few studies have examined the impacts of different exposure averaging windows. In our previous work in the NHS, our findings for all size fractions were generally consistent for exposure averaging times of 12 to 48 months. 10, 15 The HRs were most consistent in analyses of PM 10 and PM 2.5 to 10 . This is in contrast to our current findings that show lower HRs for the 60-and 120-month exposure averaging times compared to the 12-and 24-month averages. However, the high correlations in exposures across time windows make it difficult to determine whether these differences are solely due to chance or are related to true differences in risk.
The limitations of this study should be noted. The NHS predominantly comprises middle-aged and elderly white women who at one time were nurses. Therefore, our results may not be generalizable to men or to more racially or socioeconomically diverse populations. Although we used a sophisticated spatio-temporal model to estimate ambient PM concentrations at the home addresses of each participant, measurement error may still be present. We do not have information on time-activity patterns, or housing characteristics that may influence the infiltration of ambient PM. Additionally, the lack of available monitoring information on PM 2.5 prior to 1999 and the need to estimate PM 2.5 to 10 concentrations by subtraction for the full time period could also lead to exposure misclassification. Although we had timevarying information on a number of confounders, residual confounding is still always a concern even though validation studies suggest accurate reporting in this group. 37 The issue of residual confounding is also raised by our observation of confounding by socioeconomic status, both individual and area level; our inability to control for small-scale spatial autocorrelation; or spatial patterns in our selected confounders and effect modifiers, including the potentially strong spatial patterns of diabetes prevalence in the United States. This study also has notable strengths, including extensive follow-up, a large number of well-validated cases of CVD, as well as close to 20 years of monthly ambient PM predictions. Compared to a number of studies with only mortality data, we had the ability to examine incident cases. Finally, we have time-varying information available on a variety of confounders and effect modifiers of interest, which allowed us to evaluate the importance of effect modification independent of key cardiovascular risk factors.
In conclusion, in this nationwide population of middle-aged and older women, exposures to PM were associated with small, but non-statistically significant increases in the risk of incident cardiovascular disease. This risk was elevated and statistically significant among women with diabetes. There also were suggestions of effect modification by age and region; however, these were not consistent across PM size fractions, time periods of follow-up, or outcomes. Overall, this study adds to the literature on chronic exposures to air pollution with cardiovascular outcomes, and adds to the limited body of knowledge identifying especially susceptible populations.
